Drug data last refreshed 4h ago · AI intelligence enriched Yesterday
AFRINOL is an oral extended-release tablet containing pseudoephedrine sulfate, a sympathomimetic decongestant used to relieve nasal congestion associated with colds, allergies, and sinus conditions. It works by stimulating alpha-adrenergic receptors to reduce nasal mucosa vasodilation and swelling.
As a mature product approaching loss of exclusivity with moderate competitive pressure (30), brand team resources are likely being consolidated or redirected to newer assets.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Bioequivalence Study of Desloratadine and Pseudoephedrine Sulfate Extended-release Tablets Under Fasting Conditions
Working on AFRINOL offers limited career upside due to its approaching LOE and minimal linked job openings. This role is best suited for early-career professionals seeking OTC/primary care experience or those willing to manage a declining brand through transition.
Worked on AFRINOL at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.